SCNI (Scinai Immunotherapeutics Ltd. American Depositary Shares) Stock Analysis - Community
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of May 20, 2026, SCNI trades at $0.48 with a market cap of $2.22M and a P/E ratio of 0.00. SCNI moved -3.56% today. Year to date, SCNI is -30.35%; over the trailing twelve months it is -81.98%. Its 52-week range spans $0.45 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade SCNI?
Rallies community data for SCNI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
BEATY ELWIN M bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELAINE E bought 80.00K (~$5.20K) on Dec 14, 2007.
BEATY ELWIN M sold 80.00K (~$5.20K) on Dec 14, 2007.
SCNI Analyst Consensus
SCNI analyst coverage data. Average price target: $0.00.
Common questions about SCNI
How does the Rallies community trade SCNI?
Rallies community data for SCNI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for SCNI?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for SCNI when enough community data is available.
Is SCNI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.